Egypt participates in Ukraine International Travel, Tourism Exhibition    139 Palestinians killed in Israeli strikes on Gaza    Palestinian under attack in 73rd anniversary of Nakba Day    Egypt's Health Ministry launches awareness campaigns against COVID-19    Egypt partakes in drafting OECD Recommendations on AI    Palestine's Telecom Ministry names top social media supportive hashtags for maximum engagement    Egypt fines mobile operators EGP 20m for number portability violations    Sudan pledges to investigate killing of 2 protestors during peaceful sit-in    Grand Egyptian Museum finishes installing Tutankhamun's 3rd shrine    Egypt discovers several ancient tombs in Sohag's Al-Hamdiya necropolis    Egypt scales up readiness of hospitals nationwide for Eid Al-Fitr holidays    Egyptian hospitals in Sinai on alert amid Israeli aggression on Gaza    Egypt announces Thursday 1st day of Eid Al-Fitr    Nuweiba: Egypt's paradise of serenity    Egypt's current account deficit jumps to $7.6 bln in 1H of FY2020/21: CBE    Egypt's trade deficit down 1.2% to $3.34bn in February 2021: CAPMAS    Global economic recovery to improve debt service coverage ratios: Moody's    Egypt's Parliament discusses abolishing imprisonment for female debtors    India signs an agreement to buy 300,000 doses of Remdesivir from Eva Pharma    Egypt will locally manufacture first 2m Sinovac vaccine doses by June-end    2021 South East European Film Festival celebrates cinematic diversity of 18 countries    Turkey seeks to restore 'historic unity' with Egyptian people: Erdogan    Elneny's Arsenal targets 'remontada' in Europa League semi-finals    Zamalek eye return to victories at expense of Smouha in Egyptian Premier League    Al Ahly face injuries as they take on Al Ittihad Alexandria    Egypt buys 30 Rafale fighter jets from France    Direct flights between Russia and Egypt will resume in June, Ambassador    Egypt's Ahly is establishing a new stadium, expected to be 'sports complex'    Blinken presses Ethiopia's Abiy to ensure full withdrawal of Eritrean troops from Tigray    Forces opposed to Somali president control parts of Mogadishu    Nine people executed in Egypt over Kerdasa police killings in 2013    UEFA investigating Ibrahimovic's alleged ties to betting company    61 doctors died from coronavirus since start of April: Egypt's medical syndicate    Egypt targets 5.6% inflation rate in FY2020/21, 6% in FY2021/22    Egypt allocates EGP 132 bln to modernise railway system: Transport minister    Real Madrid not thinking about any Super League sanctions: Zidane    Total declares force majeure on Mozambique LNG after attacks    All the winners at the 93rd Academy Awards    Egypt's Ahly granted approval to build new stadium on Cairo outskirts    Aswan Int'l Women's Film Festival dedicates 5th edition to Kawthar Heikal    BREAKING: Egypt's information minister Osama Heikal resigns amid parliamentary criticism    'War was not Egypt's aim, but peace was the ultimate goal,' Sisi says on Sinai Liberation Day anniversary    Factbox: Key nominations for the 2021 Academy Awards    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    Veteran Egyptian journalist Makram Mohamed Ahmed passes away at 86    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





China OKs 1st homegrown vaccine said to be 79.3% effective
Published in Ahram Online on 31 - 12 - 2020

Chinese health regulators said Thursday that they have given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm.
The two-dose vaccine is the first approved for general use in China. The go-ahead comes as the country has begun to vaccinate 50 million people before the Lunar New Year holiday in February.
Conditional approval means that research is still ongoing, the company will be required to submit follow-up data as well as reports of any adverse effects after the vaccine is sold on the market, Chen Shifei, the deputy commissioner of the National Medical Products Administration, told a news conference.
The company “must continuously update the vaccine's instructions, labels and report to the agency,” Shifei said.
The vaccine was developed by the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that preliminary data from last-stage trials had shown it to be 79.3% effective.
It is an inactive vaccine, which means the virus was grown in a lab and then killed. The germ is then injected into the body to generate an immune response.
Final proof of its effectiveness will depend on publication of more data.
Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.8 million people.
In addition to the emergency vaccinations already underway, China plans to start vaccinating high-risk population, such as seniors as well as people with existing chronic illnesses. Officials did not say what percentage of the population they will vaccinate in China.
“This is different in every country but the general thinking is that it has to reach 60% to protect the entire population,” said Zeng Yixin, vice minister of the National Health Commission.
Under emergency use, 4.5 million doses have already been given, including 3 million in the past two weeks, Zeng said.
Practically, the conditional approval means that the drug or product in question may be restricted for certain age groups, according to Tao Lina, a former government immunologist.
Officials declined to name a particular price and gave conflicting statements about it. “It will certainly be in the limit of what people can afford,” said Zheng Zhongwei, another National Health Commission official.
A minute later, Zeng, the NHC official, stepped in to say that the vaccines “will definitely be free for the public.”
The vaccine is already under mass production, though officials did not answer questions about current production capacity.
Approval of China's vaccine could also mean hope for countries around the world who may not have access to the Pfizer or Moderna shots, which have stricter cold chain requirements. Sinopharm's vaccine is able to be stored at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit), or a normal refrigeration temperature.
Sinopharm's vaccine has already been approved in the United Arab Emirates and Bahrain, and is slated for use next in Morroco.
Other countries have also been buying doses of another Chinese vaccine candidate, made by Sinovac Biotech. Turkey received the shipments this week of 3 million doses. Indonesia and Brazil have all purchased Sinovac's vaccines.
China is eager to distribute its vaccines globally, driven by a desire to repair the damage to its image by the pandemic that started a year ago in the central city of Wuhan.
President Xi Jinping has vowed to donate the vaccine as a public good to the world and China has joined COVAX, a global plan for equal distribution and access.
“We eagerly await Chinese vaccines to be included in COVAX's vaccine bank soon and get WHO prequalification soon as well,” said Shen Bo, a Foreign Ministry official.
The vaccine standards were developed in “close cooperation” with the WHO, officials said.
Meeting the WHO qualification could go some way toward assuring the rest of the world about the quality and efficacy of Chinese vaccines, which already face a reputation problem back home. It would also open the path for Chinese vaccines to be distributed in COVAX and potentially in countries that don't have their own regulatory agencies.
“This is very exciting that there is another vaccine and one that can be distributed in locations that don't have the cold chain,” said Ashley St. John, an immunologist at the Duke-NUS Medical School in Singapore. “But at the same time we have to temper the excitement. We have to understand the long term efficacy, effect on transmission and effect on severe disease.”


Clic here to read the story from its source.